NGR6200 Respiratory Quiz With Complete
Solutions
A ||patient ||with ||COPD ||has ||been ||prescribed ||home ||oxygen. ||How ||often ||must ||the ||patient ||
wear ||the ||nasal ||cannula ||for ||optimal ||benefit?
a. ||only ||as ||needed
b. ||4-6 ||hours ||per ||day
c. ||10-12 ||hours ||per ||day
d. ||18 ||hours ||a ||day ||- ||CORRECT ||ANSWER✔✔-d. ||
- ||18 ||hours ||a ||day
Question ||5:
The ||CURB ||65 ||is ||used ||to:
a. ||Diagnosis ||DVT
b. ||Predict ||prognosis ||in ||CAP ||and ||help ||determine ||outpatient ||vs ||inpatient ||treatment
c. ||Assess ||risk ||for ||SBE
d. ||Assess ||need ||for ||anticoagulation ||- ||CORRECT ||ANSWER✔✔-b. ||
- ||Predict ||prognosis ||in ||CAP ||and ||help ||determine ||outpatient ||vs ||inpatient ||treatment
,Question ||6:
The ||definitive ||test ||for ||sleep ||apnea ||is:
a. ||a ||Holter ||monitor
b. ||ABI ||measures
c. ||an ||overnight ||polysomnogram
d. ||spirometry ||- ||CORRECT ||ANSWER✔✔-c. ||
- ||an ||overnight ||polysomnogram,
spirometry ||measures ||Asthma ||and ||COPD
Question ||7
The ||nurse ||practitioner ||assesses ||a ||PPD ||on ||the ||forearm ||of ||a ||patient ||being ||screened ||for ||
employment. ||The ||induration ||is ||7 ||mm. ||How ||should ||this ||finding ||be ||interpreted?
a. ||negative, ||insignificant
b. ||moderately ||significant, ||requiring ||chest ||radiograph
c. ||moderately ||significant, ||requiring ||sputum ||culture
d. ||significant, ||requiring ||treatment ||- ||CORRECT ||ANSWER✔✔-a. ||
- ||negative, ||insignificant
Question ||8
, Treatment ||of ||latent ||TB ||consists ||of:
||
a. ||a ||four ||drug ||cocktail ||of ||anti ||mycobacterial ||agents
b. ||no ||treatment ||is ||recommended ||if ||the ||CXR ||is ||negative
c. ||isoniazid ||daily ||for ||9 ||months
d. ||ethambutol ||for ||6 ||months ||- ||CORRECT ||ANSWER✔✔-c. ||
- ||isoniazid ||daily ||for ||9 ||months
Question ||9:
What ||is ||the ||desired ||action ||of ||ipratropium ||bromide ||(Atrovent) ||when ||used ||in ||treating ||
chronic ||obstructive ||pulmonary ||disease ||(COPD)?
a. ||increase ||mucociliary ||clearance
b. ||reduce ||alveolar ||volume
c. ||bronchodilator ||effect
d. ||mucolytic ||agent ||- ||CORRECT ||ANSWER✔✔-c. ||
bronchodilator ||effect; ||it ||antagonized ||acetylcholine ||receptors ||producting ||bronchodilation. ||
NOTE:
*atrovent ||nasal ||spray ||antagonizes ||ACh ||receptors ||AND ||inhibits ||nasal ||serous/seromucos ||
glands ||as ||an ||anticholinergic ||agent.
Question ||10:
Solutions
A ||patient ||with ||COPD ||has ||been ||prescribed ||home ||oxygen. ||How ||often ||must ||the ||patient ||
wear ||the ||nasal ||cannula ||for ||optimal ||benefit?
a. ||only ||as ||needed
b. ||4-6 ||hours ||per ||day
c. ||10-12 ||hours ||per ||day
d. ||18 ||hours ||a ||day ||- ||CORRECT ||ANSWER✔✔-d. ||
- ||18 ||hours ||a ||day
Question ||5:
The ||CURB ||65 ||is ||used ||to:
a. ||Diagnosis ||DVT
b. ||Predict ||prognosis ||in ||CAP ||and ||help ||determine ||outpatient ||vs ||inpatient ||treatment
c. ||Assess ||risk ||for ||SBE
d. ||Assess ||need ||for ||anticoagulation ||- ||CORRECT ||ANSWER✔✔-b. ||
- ||Predict ||prognosis ||in ||CAP ||and ||help ||determine ||outpatient ||vs ||inpatient ||treatment
,Question ||6:
The ||definitive ||test ||for ||sleep ||apnea ||is:
a. ||a ||Holter ||monitor
b. ||ABI ||measures
c. ||an ||overnight ||polysomnogram
d. ||spirometry ||- ||CORRECT ||ANSWER✔✔-c. ||
- ||an ||overnight ||polysomnogram,
spirometry ||measures ||Asthma ||and ||COPD
Question ||7
The ||nurse ||practitioner ||assesses ||a ||PPD ||on ||the ||forearm ||of ||a ||patient ||being ||screened ||for ||
employment. ||The ||induration ||is ||7 ||mm. ||How ||should ||this ||finding ||be ||interpreted?
a. ||negative, ||insignificant
b. ||moderately ||significant, ||requiring ||chest ||radiograph
c. ||moderately ||significant, ||requiring ||sputum ||culture
d. ||significant, ||requiring ||treatment ||- ||CORRECT ||ANSWER✔✔-a. ||
- ||negative, ||insignificant
Question ||8
, Treatment ||of ||latent ||TB ||consists ||of:
||
a. ||a ||four ||drug ||cocktail ||of ||anti ||mycobacterial ||agents
b. ||no ||treatment ||is ||recommended ||if ||the ||CXR ||is ||negative
c. ||isoniazid ||daily ||for ||9 ||months
d. ||ethambutol ||for ||6 ||months ||- ||CORRECT ||ANSWER✔✔-c. ||
- ||isoniazid ||daily ||for ||9 ||months
Question ||9:
What ||is ||the ||desired ||action ||of ||ipratropium ||bromide ||(Atrovent) ||when ||used ||in ||treating ||
chronic ||obstructive ||pulmonary ||disease ||(COPD)?
a. ||increase ||mucociliary ||clearance
b. ||reduce ||alveolar ||volume
c. ||bronchodilator ||effect
d. ||mucolytic ||agent ||- ||CORRECT ||ANSWER✔✔-c. ||
bronchodilator ||effect; ||it ||antagonized ||acetylcholine ||receptors ||producting ||bronchodilation. ||
NOTE:
*atrovent ||nasal ||spray ||antagonizes ||ACh ||receptors ||AND ||inhibits ||nasal ||serous/seromucos ||
glands ||as ||an ||anticholinergic ||agent.
Question ||10:
